0

Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy

International Agency for Research on Cancer, 2007

IARC monographs on the evaluation of carcinogenic risks to humans, 91, 1-528

PMID 18756632 Source

Abstract

No abstract available for this article.

Topics

Contraception/Comparison > Side Effects > Hormonal ContraceptionContraception/Comparison > FABM vs Hormonal > Side EffectsPerimenopause/Menopause > HRT > Risks
combined oral contraceptive health risks, estrogen progestogen contraceptive safety, birth control pill side effects, hormonal contraception cancer risk, combined hormonal contraceptive complications, estrogen progestogen menopausal therapy, HRT hormone replacement therapy risks, IARC monograph contraceptives, oral contraceptive pill carcinogenicity, combined contraceptive cardiovascular effects, hormonal birth control long term effects

Cite this article

IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (2007). Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy. *IARC monographs on the evaluation of carcinogenic risks to humans*.

Related articles